generalized epilepsy with febrile seizures plus
MeSH: C565809ORPHA: 363872 Treatments Available
Overview
idiopathic generalized epilepsy that is characterized by febrile seizures often with accessory afebrile generalized tonic-clonic seizures with childhood onset
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Valproic Acid | Oral tablets 250mg, 500mg; Oral solution 250mg/5mL; IV infusion 100mg/mL | FDA Approved | 12 | 7d |
| Levetiracetam | Oral tablet 250mg, 500mg, 750mg, 1000mg; Oral solution 100mg/mL; IV infusion 500mg/5mL | FDA Approved, EMA Approved | 11 | 3d |
Clinical Presentation
Signs and symptoms associated with generalized epilepsy with febrile seizures plus, sourced from HPO and Orphanet clinical annotations.
Generalized-onset seizureGeneralized non-motor (absence) seizureFebrile seizure (within the age range of 3 months to 6 years)AtaxiaHypotoniaBilateral tonic-clonic seizureGeneralized myoclonic seizureIncoordinationDevelopmental regressionCortical dysplasiaPoor fine motor coordinationGeneralized cerebral atrophy/hypoplasiaAtonic seizureEEG with spike-wave complexesAtypical absence status epilepticusCognitive impairmentAutistic behaviorAnxietyTremorPes planusBradykinesiaStatus epilepticusFocal impaired awareness seizureLimited knee extensionTalipes valgusFocal-onset seizureObsessive-compulsive traitTibial torsion
Classification & Codes
MeSH Code
C565809Orphanet Code
ORPHA:36387generalized epilepsy with febrile seizures plus
| MeSH | C565809 |
| Orphanet | ORPHA:36387 |
| Treatments | 2 drug(s) |
| Symptoms on record | 28 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO